The global COVID-19 pandemic has been a recurring theme throughout the 2020 U.S. elections, and its health and economic consequences will be felt far beyond November 3. In this Kenan Insight, we look at both the challenges and potential opportunities the pandemic has created for accelerating innovations in healthcare delivery and pharmaceutical development.